-
1
-
-
0022876328
-
Huntington's disease. Pathogenesis and management
-
1:CAS:528:DyaL2sXjsVCr 2877396
-
Martin JB, Gusella JF. Huntington's disease. Pathogenesis and management. N Engl J Med. 1986;315:1267-76.
-
(1986)
N Engl J Med
, vol.315
, pp. 1267-1276
-
-
Martin, J.B.1
Gusella, J.F.2
-
2
-
-
0031916812
-
Complex i defect in muscle from patients with Huntington's disease
-
1:STN:280:DyaK1c7msFertw%3D%3D 9506560
-
Arenas J, Campos Y, Ribacoba R, et al. Complex I defect in muscle from patients with Huntington's disease. Ann Neurol. 1998;43:397-400.
-
(1998)
Ann Neurol
, vol.43
, pp. 397-400
-
-
Arenas, J.1
Campos, Y.2
Ribacoba, R.3
-
3
-
-
33750975898
-
Increased apoptosis, huntingtin inclusions and altered differentation in muscle cell cultures from Huntington's disease subjects
-
1:CAS:528:DC%2BD28XhtF2nsrfP 16729030
-
Ciammola A, Sassone J, Alberti L, et al. Increased apoptosis, huntingtin inclusions and altered differentation in muscle cell cultures from Huntington's disease subjects. Cell Death Differ. 2006;13:2068-78.
-
(2006)
Cell Death Differ
, vol.13
, pp. 2068-2078
-
-
Ciammola, A.1
Sassone, J.2
Alberti, L.3
-
4
-
-
0033914747
-
Abnormal in vivo skeletal muscle energy metabolism in Huntington's disease and dentatorubropallidoluysian atrophy
-
1:STN:280:DC%2BD3czltVOitA%3D%3D 10894218
-
Lodi R, Schapira AH, Manners D, et al. Abnormal in vivo skeletal muscle energy metabolism in Huntington's disease and dentatorubropallidoluysian atrophy. Ann Neurol. 2000;48:72-6.
-
(2000)
Ann Neurol
, vol.48
, pp. 72-76
-
-
Lodi, R.1
Schapira, A.H.2
Manners, D.3
-
5
-
-
22844440902
-
Mitochondrial impairment in patients and asymptomatic mutation carriers of Huntington's disease
-
15704211
-
Saft C, Zange J, Andrich J, et al. Mitochondrial impairment in patients and asymptomatic mutation carriers of Huntington's disease. Mov Disord. 2005;20:674-9.
-
(2005)
Mov Disord
, vol.20
, pp. 674-679
-
-
Saft, C.1
Zange, J.2
Andrich, J.3
-
6
-
-
85028072366
-
Skeletal muscle characteristics and mitochondrial function in Huntington disease patients
-
Gehrig SM, Petersen JA, Frese S, et al. Skeletal muscle characteristics and mitochondrial function in Huntington disease patients. Mov Disord. 2017. doi: 10.1002/mds.27031.
-
(2017)
Mov Disord.
-
-
Gehrig, S.M.1
Petersen, J.A.2
Frese, S.3
-
7
-
-
42549092746
-
Wheel running from a juvenile age delays onset of specific motor deficits but does not alter protein aggregate density in a mouse model of Huntington's disease
-
18380890 2335112
-
Van Dellen A, Cordery PM, Spires TL, Blakemore C, Hannan AJ. Wheel running from a juvenile age delays onset of specific motor deficits but does not alter protein aggregate density in a mouse model of Huntington's disease. BMC Neurosci. 2008;9:34.
-
(2008)
BMC Neurosci
, vol.9
, pp. 34
-
-
Van Dellen, A.1
Cordery, P.M.2
Spires, T.L.3
Blakemore, C.4
Hannan, A.J.5
-
8
-
-
84882792190
-
Exercise attenuates neuropathology and has greater benefit on cognitive than motor deficits in the R6/1 Huntington's disease mouse model
-
23911978
-
Harrison DJ, Busse M, Openshaw R, Rosser AE, Dunnett SB, Brooks SP. Exercise attenuates neuropathology and has greater benefit on cognitive than motor deficits in the R6/1 Huntington's disease mouse model. Exp Neurol. 2013;248:457-69.
-
(2013)
Exp Neurol
, vol.248
, pp. 457-469
-
-
Harrison, D.J.1
Busse, M.2
Openshaw, R.3
Rosser, A.E.4
Dunnett, S.B.5
Brooks, S.P.6
-
9
-
-
84991666180
-
Exercise effects in Huntignton disease
-
1:CAS:528:DC%2BC28XhslSqs7zO 27747393
-
Frese S, Petersen JA, Ligon-Auer M, et al. Exercise effects in Huntignton disease. J Neurol. 2017;264:32-9.
-
(2017)
J Neurol
, vol.264
, pp. 32-39
-
-
Frese, S.1
Petersen, J.A.2
Ligon-Auer, M.3
-
11
-
-
10744228606
-
Endurance training in humans leads to fiber type-specific increases in levels of peroxisome proliferator-activated receptor-gamma coactivator-1 and peroxisome proliferator-activated receptor-alpha in skeletal muscle
-
1:CAS:528:DC%2BD3sXpsFagsL0%3D 14633846
-
Russell AP, Feilchenfeldt J, Schreiber S, et al. Endurance training in humans leads to fiber type-specific increases in levels of peroxisome proliferator-activated receptor-gamma coactivator-1 and peroxisome proliferator-activated receptor-alpha in skeletal muscle. Diabetes. 2003;52:2874-81.
-
(2003)
Diabetes
, vol.52
, pp. 2874-2881
-
-
Russell, A.P.1
Feilchenfeldt, J.2
Schreiber, S.3
-
12
-
-
84977665134
-
One bout of vibration exercise with vascular occlusion activates satellite cells
-
26663352
-
Aguayo D, Mueller SM, Boutellier U, et al. One bout of vibration exercise with vascular occlusion activates satellite cells. Exp Physiol. 2016;101(2):295-307.
-
(2016)
Exp Physiol
, vol.101
, Issue.2
, pp. 295-307
-
-
Aguayo, D.1
Mueller, S.M.2
Boutellier, U.3
-
13
-
-
84980384034
-
Altered skeletal muscle (mitochondrial) properties in patients with mitochondrial DNA single deletion myopathy
-
27473873 4966582
-
Gehrig SM, Mihaylova V, Frese S, et al. Altered skeletal muscle (mitochondrial) properties in patients with mitochondrial DNA single deletion myopathy. Orphanet J Rare Dis. 2016;11:105.
-
(2016)
Orphanet J Rare Dis
, vol.11
, pp. 105
-
-
Gehrig, S.M.1
Mihaylova, V.2
Frese, S.3
-
14
-
-
84884255728
-
Improvements in exercise performance with high-intensity interval training coincide with an increase in skeletal muscle mitochondrial content and function
-
23788574
-
Jacobs RA, Flück D, Bonne TC, et al. Improvements in exercise performance with high-intensity interval training coincide with an increase in skeletal muscle mitochondrial content and function. J Appl Physiol. 2013;115:785-93.
-
(2013)
J Appl Physiol
, vol.115
, pp. 785-793
-
-
Jacobs, R.A.1
Flück, D.2
Bonne, T.C.3
-
15
-
-
0027931039
-
Biochemical and molecular investigations in respiratory chain deficiencies
-
1:CAS:528:DyaK2cXltlWjsLc%3D 7955428
-
Rustin P, Chretien D, Bourgeron T, et al. Biochemical and molecular investigations in respiratory chain deficiencies. Clin Chim Acta. 1994;228:35-51.
-
(1994)
Clin Chim Acta
, vol.228
, pp. 35-51
-
-
Rustin, P.1
Chretien, D.2
Bourgeron, T.3
-
16
-
-
78651364800
-
Molecular and biochemical characterisation of a novel mutation in POLG associated with Alpers syndrome
-
Schaller A, Hahn D, Jackson CB, et al. Molecular and biochemical characterisation of a novel mutation in POLG associated with Alpers syndrome. BMC Neurol. 2001;11:4.
-
(2001)
BMC Neurol
, vol.11
, pp. 4
-
-
Schaller, A.1
Hahn, D.2
Jackson, C.B.3
-
17
-
-
0035231595
-
Assaying mitochondrial respiratory complex activity in mitochondria isolated from human cells and tissues
-
1:CAS:528:DC%2BD3MXktlCms78%3D 11381612
-
Birch-Machin MA, Turnbull DM. Assaying mitochondrial respiratory complex activity in mitochondria isolated from human cells and tissues. Methods Cell Biol. 2001;65:97-117.
-
(2001)
Methods Cell Biol
, vol.65
, pp. 97-117
-
-
Birch-Machin, M.A.1
Turnbull, D.M.2
-
18
-
-
0014578265
-
The kinetic properties of citrate synthase from rat liver mitochondria
-
1:CAS:528:DyaF1MXltV2gtr4%3D 5820645 1184933
-
Shepherd D, Garland PB. The kinetic properties of citrate synthase from rat liver mitochondria. Biochem J. 1969;114:597-610.
-
(1969)
Biochem J
, vol.114
, pp. 597-610
-
-
Shepherd, D.1
Garland, P.B.2
-
19
-
-
80053563920
-
Combined effects of whole-body vibration, resistance exercise, and vascular occlusion on skeletal muscle and performance
-
1:STN:280:DC%2BC3Mfot1CisA%3D%3D
-
Item F, Denkinger J, Fontana P, Weber M, Boutellier U, Toigo M. Combined effects of whole-body vibration, resistance exercise, and vascular occlusion on skeletal muscle and performance. Eur J Appl Physiol. 2011;32:781-7.
-
(2011)
Eur J Appl Physiol
, vol.32
, pp. 781-787
-
-
Item, F.1
Denkinger, J.2
Fontana, P.3
Weber, M.4
Boutellier, U.5
Toigo, M.6
-
20
-
-
84904264273
-
The relationship between skeletal muscle mitochondrial citrate synthase activity and whole body oxygen uptake adaptations in response to exercise training
-
25057335 4106645
-
Vigelso A, Andersen NB, Dela F. The relationship between skeletal muscle mitochondrial citrate synthase activity and whole body oxygen uptake adaptations in response to exercise training. Int J Physiol Pathophysiol Pharmacol. 2014;6:84-101.
-
(2014)
Int J Physiol Pathophysiol Pharmacol
, vol.6
, pp. 84-101
-
-
Vigelso, A.1
Andersen, N.B.2
Dela, F.3
-
21
-
-
84998694371
-
Enhanced mitochondrial biogenesis ameliorates disease phenotype in a full-length mouse model of Huntington's disease
-
1:CAS:528:DC%2BC28XitFert7rM 27008868 5081058
-
Chandra A, Sharma A, Calingasan NY, et al. Enhanced mitochondrial biogenesis ameliorates disease phenotype in a full-length mouse model of Huntington's disease. Hum Mol Genet. 2016;25:2269-82.
-
(2016)
Hum Mol Genet
, vol.25
, pp. 2269-2282
-
-
Chandra, A.1
Sharma, A.2
Calingasan, N.Y.3
-
22
-
-
84863011541
-
Pharmacologic activation of mitochondrial biogenesis exerts widespread beneficial effects in transgenic mouse model of Huntington's disease
-
1:CAS:528:DC%2BC38XitFCnsbY%3D 22095692
-
Johri A, Calingasan NY, Hennessey TM, et al. Pharmacologic activation of mitochondrial biogenesis exerts widespread beneficial effects in transgenic mouse model of Huntington's disease. Hum Mol Genet. 2012;21:1124-37.
-
(2012)
Hum Mol Genet
, vol.21
, pp. 1124-1137
-
-
Johri, A.1
Calingasan, N.Y.2
Hennessey, T.M.3
-
23
-
-
84929207081
-
Mitochondrial modulators in experimental Huntington's disease: Reversal of mitochondrial dysfunctions and cognitive defects
-
1:CAS:528:DC%2BC2MXjs1yisro%3D 25976011
-
Mehrotra A, Kanwal A, Banerjee SK, Sandhir R. Mitochondrial modulators in experimental Huntington's disease: reversal of mitochondrial dysfunctions and cognitive defects. Neurobiol Aging. 2015;36:2186-200.
-
(2015)
Neurobiol Aging
, vol.36
, pp. 2186-2200
-
-
Mehrotra, A.1
Kanwal, A.2
Banerjee, S.K.3
Sandhir, R.4
-
24
-
-
85006021086
-
Mitochondrial dysfunction and biogenesis in neurodegenerative diseases: Pathogenesis and treatment
-
Golpich M, Amini E, Mohamed Z, Ali RA, Ibrahim NM, Ahmadini A. Mitochondrial dysfunction and biogenesis in neurodegenerative diseases: pathogenesis and treatment. CNS Neurosci. 2017;23:5-22.
-
(2017)
CNS Neurosci
, vol.23
, pp. 5-22
-
-
Golpich, M.1
Amini, E.2
Mohamed, Z.3
Ali, R.A.4
Ibrahim, N.M.5
Ahmadini, A.6
-
25
-
-
84980398108
-
Superior mitochondrial adaptations in human skeletal muscle after interval compared to continuous single-leg cycling matched for total work
-
1:CAS:528:DC%2BC28Xht1ygtL3F
-
MacInnis MJ, Zacharewicz E, Martin BJ, et al. Superior mitochondrial adaptations in human skeletal muscle after interval compared to continuous single-leg cycling matched for total work. J Phyisol. 2017;595:2955-68.
-
(2017)
J Phyisol
, vol.595
, pp. 2955-2968
-
-
MacInnis, M.J.1
Zacharewicz, E.2
Martin, B.J.3
-
26
-
-
85013224111
-
Do changes in mitochondrial quality contribute to increases in skeletal muscle oxidative capacity following endurance training
-
1:CAS:528:DC%2BC2sXisFSnt7s%3D 28074468
-
Bartlett MF, Miehm JD, Fitzgerald LF, Straight CR. Do changes in mitochondrial quality contribute to increases in skeletal muscle oxidative capacity following endurance training. J Physiol. 2017;595:1861-2.
-
(2017)
J Physiol
, vol.595
, pp. 1861-1862
-
-
Bartlett, M.F.1
Miehm, J.D.2
Fitzgerald, L.F.3
Straight, C.R.4
-
27
-
-
80052820817
-
Mitochondria: Isolation, structure and function
-
1:CAS:528:DC%2BC3MXht1CgsLvF 21708903 3208215
-
Picard M, Taivassalo T, Gouspillou G, Hepple RT. Mitochondria: isolation, structure and function. J Physiol. 2011;589:4413-21.
-
(2011)
J Physiol
, vol.589
, pp. 4413-4421
-
-
Picard, M.1
Taivassalo, T.2
Gouspillou, G.3
Hepple, R.T.4
-
28
-
-
35348941757
-
Clinical correlates of mitochondrial function in Huntington disease muscle
-
17557337
-
Turner C, Cooper JM, Schapira AH. Clinical correlates of mitochondrial function in Huntington disease muscle. Mov Disord. 2007;22:1715-21.
-
(2007)
Mov Disord
, vol.22
, pp. 1715-1721
-
-
Turner, C.1
Cooper, J.M.2
Schapira, A.H.3
|